Skip to content
About
Clinical Trials
Resources
Contact
Menu
About
Clinical Trials
Resources
Contact
ANHL1931
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination with Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Status:
Open
Trial Type:
Lymphoma
Contact:
Dr. Adam Olszewski
aolszewski@lifespan.org